Dr. Lisa Crossley reports

RELIQ HEALTH TECHNOLOGIES, INC. PROVIDES UPDATE ON STATUS OF MANAGEMENT CEASE TRADE ORDER

Reliq Health Technologies Inc. has provided this update on the status of a management cease trade order granted on Oct. 31, 2023 (the MCTO), by the British Columbia Securities Commission under National Policy 12-203 -- Management Cease Trade Order. On Oct. 31, 2023, the company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying management's discussion and analysis for the fiscal year ended June 30, 2023, beyond the period prescribed under applicable Canadian securities laws.

"We are working very hard to complete all of the remaining audit tasks as soon as possible," said Dr. Lisa Crossley, chief executive officer at Reliq Health Technologies. "We regret the inconvenience to our shareholders and thank them for their patience. As previously disclosed, we recently completed a private placement to allow the company to expand its U.S. operations team. The existing U.S. team has spent a significant amount of time working with our customers, suppliers and partners to provide documentation required for the audit and to co-ordinate virtual meetings between a number of these groups and the auditors, which has created a bottleneck in the audit process this year that we will ensure is addressed through our new hires. The private placement process itself consumed management's time and further contributed to the delay in filing, but we are working to complete the remaining audit activities as quickly as possible. The company will provide regular updates on its progress via news release and will notify shareholders of the date and log-in details for the webinar to discuss the annual audited financials as soon as the filing date is finalized."

During the MCTO, the general investing public will continue to be able to trade in the company's listed common shares. However, the company's chief executive officer and chief financial officer will not be able to trade in the company's shares.

Other than as disclosed in this news release, there are no material changes to the information contained in the default announcement. The company confirms that it intends to satisfy the provisions of NP 12-203 and will continue to issue biweekly default status reports for so long as it remains in default of the annual filings requirement.

About Reliq Health Technologies Inc.

Reliq is a rapidly growing global health care technology company that specializes in developing innovative virtual care solutions for the multibillion-dollar health care market. Reliq's powerful iUGO Care platform supports care co-ordination and community-based virtual health care. iUGO Care allows complex patients to receive high-quality care at home, improving health outcomes, enhancing quality of life for patients and families, and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team, to prevent costly hospital readmissions and emergency room visits. Reliq trades on the TSX Venture Exchange under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN: A2AJTB.

We seek Safe Harbor.